HDFCL30ETF vs SBI Healthcare Opportunities Fund
Portfolio Overlap Analysis · HDFC vs SBI
10.8%
Low Overlap
3 common stocks · Rank #19388 of 28,292 pairs
Common Holdings (3)
| Stock | Wt% in HDFCL30ETF | Wt% in SBI Healthcare Opportunities | Overlap |
|---|---|---|---|
Apollo Hospitals Enterprise Ltd. Healthcare Services | 5.76% | 3.73% | 3.73% |
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology | 10.65% | 3.57% | 3.57% |
Torrent Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology | 4.25% | 3.51% | 3.51% |
Unique to HDFCL30ETF
- State Bank of India4.83%
- ICICI Bank Ltd.4.42%
- HDFC Bank Ltd.4.01%
- Hindustan Unilever Ltd.3.91%
- Nestle India Ltd.3.70%
- Titan Company Ltd.3.66%
- Britannia Industries Ltd.3.64%
- UltraTech Cement Limited3.63%
- SBI Life Insurance Company Ltd.3.59%
Unique to SBI Healthcare Opportunities
- Divi's Laboratories Ltd.7.55%
- Max Healthcare Institute Ltd.4.82%
- Acutaas Chemicals Ltd.4.77%
- Lupin Ltd.4.23%
- Aster DM Healthcare Ltd.3.85%
- Biocon Ltd.3.59%
- Laurus Labs Ltd.3.48%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology7.1% (2)
Healthcare Services3.7% (1)
Analysis
AI-generated comparative analysis coming soon.
More comparisons for HDFCL30ETF
- vs HDFC NIFTY100 Low Volatility 399.9% · 30 stocks
- vs SBI Nifty100 Low Volatility 3099.8% · 30 stocks
- vs NV30ETF84.8% · 27 stocks
- vs Nippon India Nifty Alpha Low V66.5% · 20 stocks
- vs ICICI Prudential Equity Minimu60.0% · 24 stocks
More comparisons for SBI Healthcare Opportunities
- vs HDFC Pharma and Healthcare54.8% · 16 stocks
- vs HEALETF53.4% · 12 stocks
- vs NIPPON INDIA PHARMA48.6% · 19 stocks
- vs ICICI Prudential Nifty Pharma 44.1% · 11 stocks
- vs NH44.1% · 11 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.